A preclinical HIV vaccine result is promising, not a human trial (lji.org)
The research aims to train the immune system toward antibodies that can recognize diverse HIV variants, rather than one narrow target.
HN’s enthusiasm came with the necessary asterisk: preclinical success is a starting point, not evidence that a vaccine works in people.
Sign in to save